Subject characteristics
| Control | Nonfatal | Fatal | |
| Subjects n | 8 | 8 | 8 |
| Male/female | 5/3 | 4/4 | 4/4 |
| Age yrs mean±sd | 38±14 | 39±17 | 31±16 |
| Treatment n | |||
| Bronchodilator | 0 | 8 | 8 |
| Inhaled corticosteroid | 0 | 2 | 8 |
| Oral corticosteroid | 0 | 0 | 6 |
| Asthma symptoms | Weekly 3 of 8 | Daily 7 of 8 | |
| Occasional 5 of 8 | Occasional 1 of 8 | ||
| Time off work or hospitalization due to asthma n | 0 | 1 | 7 |
| Duration of asthma, yrs mean (range) | Nil | 14 (2–36) | 18 (2–40) |
| Lung function FEV1 % pred, mean (range) | NA | NA | 68 (35–90) |
FEV1: forced expiratory volume in one second
NA: not available